Currently Viewing:
American Psychiatric Association 2019 Annual Meeting
Currently Reading
Dr David Kingdon on the Principles Underlying the Use of CBT in Psychosis
May 19, 2019
Studies Reveal Loneliness, Trauma Effects Among Minority Urban Women
May 20, 2019
Hochschild Gives Psychiatrists a View of Bridging the Political Chasm
May 20, 2019
Dr Lori Raney Outlines the Advantages and Limitations of Treating Mental Health Disorders in Primary Care Settings
May 20, 2019
Dr Steven Adelsheim Discusses Changing Stigmas Around Mental Illness in Young People
May 20, 2019
Dr Jacob Ballon: Coordinated Teams, Collaboration Are Key to Supporting People With Psychosis
May 21, 2019
TRANSFORM-2 Results on Esketamine Published, Along With Caveats
May 21, 2019
Poll Finds Most Workers Can Get Mental Health Care, but a Third Worry About Seeking It
May 21, 2019
Adam Simmons on Patient Preferences When Taking Antipsychotic Medications
May 21, 2019
Alkermes' Novel Schizophrenia Drug Shows Less Weight Gain, Addressing Top Patient Complaint
May 21, 2019
Where Culture and Science Collide: How Ethnic, Social Factors Affect Response to Psychotropic Drugs
May 22, 2019
Dr Godfrey Pearlson on the Merits of Using Biological Measures to Classify Psychiatric Diseases
May 23, 2019
Dr Isaac Galatzer-Levy Explains How a Predictive Algorithm Uses Machine Learning to Predict PTSD Risk
May 23, 2019
Dr King Davis Explains the Privacy Dangers of Digitizing Archives, Including Psychiatric Records
May 24, 2019
Dr David Kingdon Discusses How CBT Techniques Tailored to Psychosis Can Help Patients Feel Understood
May 30, 2019
Dr Jonathan Avery Discusses Causes and Consequences of Concurrent Mental Illness and Substance Use Disorders
May 31, 2019
Adam Simmons Outlines Efficacy of ALKS 3831 Across Subgroups of Patients With Schizophrenia
June 11, 2019
Dr Lori Raney Defines Integrated, Collaborative Care for Behavioral Health
June 13, 2019
Dr David Kingdon Describes How CBT Can Fit Into a Psychosis Treatment Plan
June 17, 2019
Dr Steven Adelsheim Discusses the Importance of Early Diagnosis for Young People With Psychosis
June 20, 2019
Dr Isaac Galatzer-Levy Explains the Importance of Accurately Predicting PTSD After a Traumatic Event
June 22, 2019
Dr Jonathan Avery Explains How Substance Use Affects the Care of Patients With Mental Illness
June 23, 2019
Dr David Kingdon on the Factors Predicting CBT Success in Psychosis
June 25, 2019
Adam Simmons Explains the Importance of Finding New Treatment Options for Schizophrenia
June 29, 2019

Dr Isaac Galatzer-Levy: How Tech Could Help Identify and Intervene in Mental Illness

Isaac Galatzer-Levy, PhD, assistant professor in psychiatry and bioinformatics, NYU School of Medicine, and vice president of clinical and computational neuroscience, AiCure, said that technological solutions like artificial intelligence can help identify and monitor signs of mental illness so patients can be connected with the help they need.


Isaac Galatzer-Levy, PhD, assistant professor in psychiatry and bioinformatics, NYU School of Medicine, and vice president of clinical and computational neuroscience, AiCure, said that technological solutions like artificial intelligence (AI) can help identify and monitor signs of mental illness so patients can be connected with the help they need.

Transcript

What are some future avenues in psychiatry that could be addressed using AI/machine learning?

Where I think the largest unmet need is in how we actually define and track people with mental health issues. So, what does it mean to be mentally ill? How can we see that out in the wild? How can we see when a patient is not doing well, such that we can intervene to really reduce the hard outcomes that affect their lives?

So I’ll give you an example: If you think about patients with schizophrenia or bipolar disorder or even depression, their disorders really have a cyclic nature to them where, yes, they’re sick and they need to be maintained on medication, but they have episodes that are particularly acute that have huge negative consequences in their life, lead to hospitalization, which really derails multiple aspects of their life and is very hard to come back from.

So I think that there’s a huge opportunity for technology to spot that risk early on to close the loop in terms of interventions and really move both treatment and monitoring outside of the hospital system and into the world. If we can spot patients when they’re doing poorly early on, we can intervene with them and help them. There’s actually an enormous amount of resources available to do that; we’re just not able to link the resources with the people who need them. And I see technology being a real way to achieve that.

I think that the role that AI in particular can play is in how do we actually monitor and understand how a patient is doing. So most of the work that I do right now at AiCure but also in my lab at NYU is focused on how do we identify signals of mental health functioning based on facial recognition, voice, and speech.

So if you think about a patient with depression, there’s a clear signal for what a depressed patient looks like. They talk slowly, they show a lot of negative affect on their face, they use a lot of negative content in their speech, so can we capture that kind of information and understand how a patient is doing on a day-to-day basis, and then intervene when necessary or even deploy treatments as necessary.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up